跳至主要内容
临床试验/NCT00305474
NCT00305474Unknown4 期

Identification and Treatment of the Liability to Develop Schizophrenia

Central South University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2003年12月最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
Neuropsychological - cognitive measures

研究概览

简要总结

This study seeks to determine whether adult, non-psychotic, first-degree relatives of schizophrenic patients who show specific neurocognitive deficits and negative symptoms will show improvements in these areas following a 6-month, double-blind trial of a low dose (up to 2.0 mg) of risperidone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Having at least one first-degree biological relative with schizophrenia and their age is between 19 and
  • Desire to participate in a medication trial.
  • Is able to provide informed consent.
  • Having moderate levels of negative symptoms, defined as 6 items rated 3 or higher on the Scale for the Assessment of Negative Symptoms (SANS).
  • Scoring two or more standard deviations below normal in at least one of three cognitive domains: vigilance/working memory, long-term verbal memory, and executive functions.
  • Scoring at least one standard deviation below normal in a second cognitive domain.

排除标准

  • IQ less than
  • Formal education less than 10 years.
  • History of psychotic disorders.
  • History of treatment with an antipsychotic medication.
  • A substance abuse diagnosis within 6 months of diagnosis.
  • A head injury with documented loss of consciousness exceeding 5 minutes (or subsequent cognitive deficits).
  • A history of neurologic disease or damage.
  • A medical condition with significant cognitive sequelae.
  • A history of electroconvulsive treatment.

结局指标

主要结局

Neuropsychological - cognitive measures

时间窗: 2003-2010

次要结局

  • Psychiatric Symptoms(2003-2010)

研究者

发起方
Central South University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验